Dr Reddys Laboratories (RDY) EBT (2012 - 2026)

Dr Reddys Laboratories' EBT history runs 15 years deep, the most recent figure standing at $21.8 million for Q1 2026.

• In Q1 2026, EBT fell 90.6% year-over-year to $21.8 million; the TTM figure through Mar 2026 stood at $648.6 million (down 25.03% YoY), while the FY2026 annual figure was $584.0 million, down 35.11% from the prior year.
• EBT was $21.8 million for Q1 2026 at Dr Reddys Laboratories, down from $173.3 million in the prior quarter.
• In the past five years, EBT ranged from a high of $256.5 million in Q4 2023 to a low of $199.0 in Q3 2022.
• Historically, EBT has averaged $184.2 million across 5 years, with a median of $204.8 million in 2024.
• The sharpest annual moves came in 2022 and 2023: EBT plunged 100.0% in 2022, then soared 116313338.86% in 2023.
• A 5-year view of EBT shows it stood at $162.0 million in 2022, then jumped by 58.33% to $256.5 million in 2023, then fell by 13.46% to $222.0 million in 2024, then fell by 21.95% to $173.3 million in 2025, then plunged by 87.43% to $21.8 million in 2026.
• The last three EBT figures came in at $21.8 million (Q1 2026), $173.3 million (Q4 2025), and $200.7 million (Q2 2025), per Business Quant data.